NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

CITADEL ADVISORS LLC's Holding History (CIK: 0001423053)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 635,247 Value ($000) $22,284 Avg Close $36.39 Range $28.19 - $42.00

Q3 2025

Shares 206,461 Value ($000) $5,872 Avg Close $23.97 Range $17.97 - $28.91

Q2 2025

Shares 320,143 Value ($000) $5,798 Avg Close $18.24 Range $14.06 - $22.25

Q1 2025

Shares 681,933 Value ($000) $13,959 Avg Close $22.23 Range $17.18 - $26.80

Q4 2024

Shares 975,831 Value ($000) $25,079 Avg Close $21.24 Range $15.51 - $27.29

Q3 2024

Shares 522,465 Value ($000) $8,673 Avg Close $17.30 Range $15.19 - $21.48

Q2 2024

Shares 214,154 Value ($000) $4,114 Avg Close $20.06 Range $16.62 - $24.79

Q1 2024

Shares 454,334 Value ($000) $10,745 Avg Close $20.30 Range $11.18 - $26.35

Q4 2023

Shares 21,046 Value ($000) $235 Avg Close $9.16 Range $5.63 - $11.89

Q3 2023

Shares 31,397 Value ($000) $290 Avg Close $10.83 Range $8.57 - $12.54

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	635,247	$22,284	$36.39	$28.19 - $42.00
Q3 2025	206,461	$5,872	$23.97	$17.97 - $28.91
Q2 2025	320,143	$5,798	$18.24	$14.06 - $22.25
Q1 2025	681,933	$13,959	$22.23	$17.18 - $26.80
Q4 2024	975,831	$25,079	$21.24	$15.51 - $27.29
Q3 2024	522,465	$8,673	$17.30	$15.19 - $21.48
Q2 2024	214,154	$4,114	$20.06	$16.62 - $24.79
Q1 2024	454,334	$10,745	$20.30	$11.18 - $26.35
Q4 2023	21,046	$235	$9.16	$5.63 - $11.89
Q3 2023	31,397	$290	$10.83	$8.57 - $12.54